Session 1: OPENINGChair: Prof. Gilbert Donders (BE) ISIDOG President |
| Welcome Introduction Gilbert Donders (BE) & Istvan Sziller (HU) |
| Laudatio - Bill Ledger Steven Witkin (US) |
| Keynote Lecture: How COVID affects Gynecology & Medicine Marleen Temmerman (Kenya) |
Session 2: Free Oral Communications #1 (Pregnancy)Chair: Prof. Ljubomir Petricevic (AT) |
| F.1 Mixed vaginitis in 3rd trimester of pregnancy is associated with adverse pregnancy outcomes: A cross-sectional study. Li Huanrong, Xue Fengxia (Tianjin, PRC) |
| F.2 Do pregnant women with obstetric medical history have a vaginal microbiome associated with higher recurrence risk of preterm birth? Sanne Laurijssen, Gilbert Donders, Yves Jacquemyn, Sarah Lebeer (Antwerp, BE) |
| F.3 In-vitro study of polybacterial infection of chorioamniotic membranes: modulation of immune response at maternal-fetal interface. Giovana Bento, Mariana de Castro Silva, Geovanna Cristofani Cursino, Carolina Santimaria Rampazzo, Guiherme Nastaro, Jossimara Polettini, Marcia Guimarães da Silva (São Paolo, BR) |
Session 3: Obstetric & Neonatal MicrobiologyChairs: Prof. Dace Rezeberga (LV) , Prof. Daniel Surbek (CH) |
| Chorio-Amnionitis Marian Kacerovsky (CZ) |
| Vaginitis/Vaginosis in pregnancy in East Congo Lisa Himschoot (BE) |
| Vaginal viruses in pregnancy Steven Witkin (US) |
| Caesarean section, microbiome & childhood development Daniel Surbek (CH) |
Session 4: Prevention of Materno-Fetal InfectionChair: Prof. Istvan Sziller (HU) |
| Mycoplasma genitalium in women in Germany Anja Potthoff (DE) |
| Maternal immunization Kirsten Maertens (BE) |
| SARS-CoV-2 vaccination Svitrigaile Grinceviene (LT) |
| Clinical conundrum: Two maternal sepsis deaths Peter Greenhouse (GB) |
Session 5: Lunch Symposium sponsored by Medinova |
| Update on “ProPreB” trial Prof. Gilbert Donders (BE) |
| Management of abnormal flora in pregnancy Prof. Daniel Surbek (CH) |
Session 6: Free Oral Communications #2 (Bacterial Vaginitis)Chair: Dr. Peter Greenhouse (GB) |
| F.4 Aerobic Vaginitis diagnosis criteria combining Gram stain with clinical features: An establishment and prospective validation study Dong Mengting (Tianjing, PRC) |
| F.5 Vaginal microbial profiles of Aerobic Vaginitis: A case-control study Wang Chen (Tianjing, PRC) |
| F.6 Characteristics & diagnostic ability of vaginal microflora in patients with Aerobic Vaginitis: A comparative study with 16S-RNA sequencing Zeng Zhen, Zhang Qiongqiong, Zhang Lei (Beijing, PRC) |
| F.7 Cervicovaginal load of Gardnerella spp. is increased in immunocompetent women with persistent high-risk HPV Infection Rafael Belleti, Larissa Doddi Marcolino, Juliano Novak, Carolina Sanitá Tafner Ferreira, Aline do Nascimento Bolpetti, Gabriel da Silva Pinto, Gabriel Vitor, Ana Cristina Palmeira de Oliveira, Marcia Guimarães da Silva, Camila Marconi (São Paolo, BR) |
| F.8 Association of vaginal microecology and Cervical Intraepithelial Neoplasia among reproductive women with high-risk HPV Infection. Li Huiyang, Xie Wenjuan, Dong Mengting (Tianjing, PRC) |
| F.9 The use of menstrual cups is associated with the maintenance of healthy vaginal microbiota. Bruna Ribeiro de Andrade Ramos, Júlia Abbade Tronco, Jeniffer Sena Baptista Ferreira, Mariana de Castro Silva, Mariana Alice de Oliveira Ignácio, Beatriz Cassolatti Graciolli, Marli Terezinha Cassamassimo Duarte, Márcia Guimarães Da Silva (São Paolo, BR) |
Session 7: Vulvo-Vaginal Infections #1Chair: Prof. Gilbert Donders (BE) |
| Clinical recommendations on mixed vaginitis Qi Wenhui (PRC) |
| Lichen sclerosus and vulvodynia Werner Mendling (DE) |
| Treatment options for bacterial vaginosis Jack Sobel (US) |
Session 8: Vulvo-Vaginal Infections #2Chair: Prof. Werner Mendling (DE) |
| What can we learn from vaginal microbiome analysis? Sarah Lebeer (BE) |
| Isala project: citizen-science mapping of the vaginal microbiome structure and determinants Sarah Ahannah (BE) |
| Aerobic Vaginitis as an immune disorder Werner Mendling (DE) |
Session 9: Free Oral Communications #3 (Candida & Other)Chair: Prof. Gilbert Donders (BE) |
| F.10 Advances in vaginal microecology theory in the application of vulvovaginal candidiasis. Ma Xiaotong (Tianjing, PRC) |
| F.11 Candida biofilms in vulvovaginal candidiasis. Carmen Rodriguez-Cerdeira, Roberto Arenas (Vigo, ES) |
| F.12 Three phase 3, randomized, double-blind, placebo-controlled studies to evaluate the efficacy and safety of Oteseconazole (Vt-1161) oral capsules in subjects with recurrent vulvovaginal candidiasis. Gilbert Donders, Jack Sobel, Mark Martens, Bassem Maximos, Mahmoud Ghannoum, Amy Flynt, Thorsten Degenhardt, Karen Person, Stacey Curelop, Stephen Brand (Antwerp, BE) |
| F.13 Efficacy and safety of oral Ibrexafungerp in subjects with vulvovaginal candidiasis: Pooled data analysis from two phase 3, randomized, blinded, studies vs. placebo (VANISH-303 and VANISH-306). Nkechi Azie, David Angulo (US) |
| F.14 Dyspareunia in women: is it always vulvodynia? Jente Reumers, Gilbert Donders, Francesca Donders (Tienen, BE) |
Session 10: Sexually Transmitted InfectionsChairs: Dr. Peter Greenhouse (GB), Dr. Tatiana Ivanova-Rumantseva (RF) |
| Access to STI & HIV testing during the COVID-19 restrictions Dace Rezeberga (LV) |
| HPV and fertility Christophe Depuydt (BE) |
| Rectal & extra-genital chlamydial infection - “FemCure” Study Nicole Dukers-Muijrers (NL) |
| HPV and genital cancer in LBGTQIA+ populations Mikael Skerlev (HR) |
| Sex parties and STI prevalence Tatiana Ivanova-Rumantseva (RF) |
Session 11: Lunch Symposium sponsored by Bayer |
| Vaginal and gut microbiome – a cross talk Prof. Werner Mendling (DE) |
| Managing women with recurrent bacterial vaginosis: how does the VITA trial (lactic acid gel versus metronidazole) help inform practice Prof. Jonathan Ross (GB) |
Session 12: Lunch Symposium sponsored by Gedeon Richter |
| RVVC: Towards an optimised diagnosis Prof. Istvan Sziller (HU) |
| RVVC: Towards an optimised therapeutic approach Prof. Gilbert Donders (BE) |
Session 13: Pro- and Pre-BioticsChairs: Prof. Ljubomir Petricevic (AT), Prof. Sarah Lebeer (BE) |
| Antifungals versus probiotrics against candidal vaginitis? Sarah Lebeer (BE) |
| Do oral probiotics influence the vaginal microbiome? Ljubomir Petricevic (AT) |
| Testing of pre- and pro-biotic treatments Joana Rolo (PT) |
| Gardenella-specific endolysin treatment of metronidazole-resistant and clindamycin-tolerant bacterial vaginosis Lorenzo Corsini (IT) |
Session 14: COVID impact on Women’s HealthChairs: Prof. Gilbert Donders (BE), Prof. Istvan Sziller (HU) |
| COVID and sperm Jente Reumers (BE) |
| ISIDOG guidelines for COVID in pregnancy Francesca Donders (BE) |
| COVID and the placenta Zsofia Zolnai (HU) |
| Impact of social media & COVID on STI epidemiology Peter Greenhouse (GB) |
Conference Closing Ceremony and Awards ISIDOG Board |